Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 260

1.

Sites of differential DNA methylation between placenta and peripheral blood: molecular markers for noninvasive prenatal diagnosis of aneuploidies.

Papageorgiou EA, Fiegler H, Rakyan V, Beck S, Hulten M, Lamnissou K, Carter NP, Patsalis PC.

Am J Pathol. 2009 May;174(5):1609-18. doi: 10.2353/ajpath.2009.081038. Epub 2009 Apr 6.

2.

Systematic search for placental DNA-methylation markers on chromosome 21: toward a maternal plasma-based epigenetic test for fetal trisomy 21.

Chim SS, Jin S, Lee TY, Lun FM, Lee WS, Chan LY, Jin Y, Yang N, Tong YK, Leung TY, Lau TK, Ding C, Chiu RW, Lo YM.

Clin Chem. 2008 Mar;54(3):500-11. doi: 10.1373/clinchem.2007.098731. Epub 2008 Jan 17.

3.

Systematic identification of placental epigenetic signatures for the noninvasive prenatal detection of Edwards syndrome.

Tsui DW, Lam YM, Lee WS, Leung TY, Lau TK, Lau ET, Tang MH, Akolekar R, Nicolaides KH, Chiu RW, Lo YM, Chim SS.

PLoS One. 2010 Nov 30;5(11):e15069. doi: 10.1371/journal.pone.0015069.

4.

Epigenome-wide DNA methylation assay reveals placental epigenetic markers for noninvasive fetal single-nucleotide polymorphism genotyping in maternal plasma.

Ou X, Wang H, Qu D, Chen Y, Gao J, Sun H.

Transfusion. 2014 Oct;54(10):2523-33. doi: 10.1111/trf.12659. Epub 2014 Apr 18.

PMID:
24749853
5.

Non-invasive prenatal diagnosis of trisomy 21 by dosage ratio of fetal chromosome-specific epigenetic markers in maternal plasma.

Zhang M, Li T, Chen J, Li L, Zhou C, Wang Y, Liu W, Zhang Y.

J Huazhong Univ Sci Technolog Med Sci. 2011 Oct;31(5):687-92. doi: 10.1007/s11596-011-0583-0. Epub 2011 Oct 25.

PMID:
22038362
6.

Candidate epigenetic biomarkers for non-invasive prenatal diagnosis of Down syndrome.

Old RW, Crea F, Puszyk W, Hultén MA.

Reprod Biomed Online. 2007 Aug;15(2):227-35.

PMID:
17697502
7.

Noninvasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: Theoretical and empirical considerations.

Tong YK, Ding C, Chiu RW, Gerovassili A, Chim SS, Leung TY, Leung TN, Lau TK, Nicolaides KH, Lo YM.

Clin Chem. 2006 Dec;52(12):2194-202. Epub 2006 Oct 13.

8.

Novel Epigenetic Markers on Chromosome 21 for Noninvasive Prenatal Testing of Fetal Trisomy 21.

Lee DE, Lim JH, Kim MH, Park SY, Ryu HM.

J Mol Diagn. 2016 May;18(3):378-387. doi: 10.1016/j.jmoldx.2015.12.002. Epub 2016 Mar 4.

PMID:
26947512
9.

A microarray-based approach for the identification of epigenetic biomarkers for the noninvasive diagnosis of fetal disease.

Chu T, Burke B, Bunce K, Surti U, Allen Hogge W, Peters DG.

Prenat Diagn. 2009 Nov;29(11):1020-30. doi: 10.1002/pd.2335.

PMID:
19650061
10.

Noninvasive prenatal detection of trisomy 21 by an epigenetic-genetic chromosome-dosage approach.

Tong YK, Jin S, Chiu RW, Ding C, Chan KC, Leung TY, Yu L, Lau TK, Lo YM.

Clin Chem. 2010 Jan;56(1):90-8. doi: 10.1373/clinchem.2009.134114. Epub 2009 Oct 22.

11.

Noncoding RNA and DNA as biomarkers: toward an epigenetic fetal barcode for use in maternal plasma.

Oudejans CB.

Clin Chem. 2008 Mar;54(3):456-7. doi: 10.1373/clinchem.2007.100123. No abstract available.

12.
13.

Detection of the placental epigenetic signature of the maspin gene in maternal plasma.

Chim SS, Tong YK, Chiu RW, Lau TK, Leung TN, Chan LY, Oudejans CB, Ding C, Lo YM.

Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14753-8. Epub 2005 Oct 3.

14.

Noninvasive prenatal methylomic analysis by genomewide bisulfite sequencing of maternal plasma DNA.

Lun FM, Chiu RW, Sun K, Leung TY, Jiang P, Chan KC, Sun H, Lo YM.

Clin Chem. 2013 Nov;59(11):1583-94. doi: 10.1373/clinchem.2013.212274. Epub 2013 Jul 15.

15.

Microarray-Based Analysis of Methylation Status of CpGs in Placental DNA and Maternal Blood DNA--Potential New Epigenetic Biomarkers for Cell Free Fetal DNA-Based Diagnosis.

Hatt L, Aagaard MM, Graakjaer J, Bach C, Sommer S, Agerholm IE, Kølvraa S, Bojesen A.

PLoS One. 2015 Jul 31;10(7):e0128918. doi: 10.1371/journal.pone.0128918. eCollection 2015.

16.

DNA methylome profiling of maternal peripheral blood and placentas reveal potential fetal DNA markers for non-invasive prenatal testing.

Xiang Y, Zhang J, Li Q, Zhou X, Wang T, Xu M, Xia S, Xing Q, Wang L, He L, Zhao X.

Mol Hum Reprod. 2014 Sep;20(9):875-84. doi: 10.1093/molehr/gau048. Epub 2014 Jul 4.

PMID:
24996894
17.

Validation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y.

Nicolaides KH, Syngelaki A, Gil M, Atanasova V, Markova D.

Prenat Diagn. 2013 Jun;33(6):575-9. doi: 10.1002/pd.4103. Epub 2013 Apr 24.

PMID:
23613152
18.

Aneuploidy detection in mixed DNA samples by methylation-sensitive amplification and microarray analysis.

Brown L, Brown G, Vacek P, Brown S.

Clin Chem. 2010 May;56(5):805-13. doi: 10.1373/clinchem.2009.137877. Epub 2010 Mar 11.

19.

Differential DNA methylation as a tool for noninvasive prenatal diagnosis (NIPD) of X chromosome aneuploidies.

Della Ragione F, Mastrovito P, Campanile C, Conti A, Papageorgiou EA, Hultén MA, Patsalis PC, Carter NP, D'Esposito M.

J Mol Diagn. 2010 Nov;12(6):797-807. doi: 10.2353/jmoldx.2010.090199. Epub 2010 Sep 16.

20.

Specific transcriptional changes in human fetuses with autosomal trisomies.

Altug-Teber O, Bonin M, Walter M, Mau-Holzmann UA, Dufke A, Stappert H, Tekesin I, Heilbronner H, Nieselt K, Riess O.

Cytogenet Genome Res. 2007;119(3-4):171-84. doi: 10.1159/000112058. Epub 2008 Feb 1.

PMID:
18253026

Supplemental Content

Support Center